Effects of the DASH diet and losartan on serum urate among adults with hypertension: Results of a randomized trial
The Journal of Clinical Hypertension · 2023
DOI: 10.1111/jch.14721 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Hypertension, 2023. Verfasst von Noelle Castilla-Ojo und 5 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Hypertension, Hyperuricemia, Dietary Approaches To Stop Hypertension, Gout. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHLBI NIH HHS.
Abstract (Originalsprache)
Serum urate is a risk factor for hypertension and gout. The DASH diet and losartan independently lower blood pressure (BP); however, their effects on serum urate are understudied. We performed a post‐hoc analysis of the DASH‐losartan trial, which randomized participants with hypertension in parallel fashion to the DASH diet or a standard American diet (control) and in crossover fashion to 4‐week losartan or placebo. Serum urate was measured at baseline and after each 4‐week period. Diets were designed to maintain weight constant. We examined the effects of DASH (vs control) and/or losartan (vs placebo) on serum urate, overall and among those with baseline serum urate ≥6 mg/dL, using generalized estimating equations. Of 55 participants (mean age 52 years, 58% women, 64% Black), mean (±SD) baseline ambulatory SBP/DBP was 146±12/91±9 and mean (±SD) serum urate was 5.2±1.2 mg/dL. The DASH diet did not significantly reduce urate levels overall (mean difference −0.05 mg/dL; 95%CI: −0.39, 0.28), but did decrease levels among participants with baseline hyperuricemia (−0.33 mg/dL; 95%CI: −0.87, 0.21; P‐interaction=0.007 across hyperuricemia groups). Losartan significantly decreased serum urate (−0.23 mg/dL; 95%CI: −0.40, −0.05) with greater effects on serum urate among adults
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Harvard Medical School, Boston, Massachusetts, USA.
- Beth Israel Deaconess Medical Center/Harvard Medical School, Division of General Medicine, Boston, Massachusetts, USA.
- VA Boston Healthcare System, West Roxbury, Massachusetts, USA.
- Johns Hopkins University, School of Medicine, Department of Medicine, Division of General Internal Medicine, Baltimore, Maryland, USA.
ORCID-Profile: Stephen P Juraschek
Förderung
- NHLBI NIH HHS
Zitieren
APA
Castilla-Ojo, N., Turkson-Ocran, R. A., Conlin, P. R., Appel, L. J., Miller, E. R., & Juraschek, S. P. (2023). Effects of the DASH diet and losartan on serum urate among adults with hypertension: Results of a randomized trial. The Journal of Clinical Hypertension. https://doi.org/10.1111/jch.14721
Vancouver
Castilla-Ojo N, Turkson-Ocran RA, Conlin PR, Appel LJ, Miller ER, Juraschek SP. Effects of the DASH diet and losartan on serum urate among adults with hypertension: Results of a randomized trial. The Journal of Clinical Hypertension. 2023. doi:10.1111/jch.14721
BibTeX
@article{CastillaOjo2023,
author = {Castilla-Ojo, Noelle and Turkson-Ocran, Ruth-Alma and Conlin, Paul R and Appel, Lawrence J and Miller, Edgar R and Juraschek, Stephen P},
title = {Effects of the DASH diet and losartan on serum urate among adults with hypertension: Results of a randomized trial},
journal = {The Journal of Clinical Hypertension},
year = {2023},
doi = {10.1111/jch.14721}
}
EUVIMED